PDL BioPharma's CEO Presents at 30th Annual JP Morgan Healthcare Conference ... Seeking Alpha Daclizumab is a product which is now jointly owned between Abbott and Biogen Idec for multiple sclerosis. They reported some very nice data from one of their Phase 2/3's in patients and we anticipate seeing report of this data from the second trial in ... |
